...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith-Oncology Pipeline
6
Mar 16, 2021 08:18AM
9
Mar 18, 2021 03:12PM
6
Mar 18, 2021 04:01PM
3
Mar 18, 2021 05:10PM
6
Mar 18, 2021 06:27PM
2
Mar 19, 2021 06:49AM
4
Mar 19, 2021 11:19AM
5
Mar 19, 2021 11:23AM
6
Mar 19, 2021 11:57AM
2
Mar 22, 2021 04:08PM
3
Mar 22, 2021 05:34PM
2
Mar 23, 2021 05:33AM

As there currently isn't any real market for Zenith other than the OTC I would say that the value is what someone would pay for a LARGE  # of shares, not the paltry few thousand that trade daily.  And as there is no market, there is no large scale value for anyone hoping to exit anytime soon.

 

Not suggesting that Zenith doesn't have value, it is just impossible to unlock that value at the moment.   At this rate it WILL be my estate settling the dispostion of the shares.  Based on average life expectancy I have used up one third of the time I have left waiting.  10 years in and hopefully at least 20 years (of life expectancy not share ownership) to go.  

Long and no longer very strong. 

4
Mar 23, 2021 09:16AM
8
Mar 23, 2021 01:45PM
4
Mar 23, 2021 02:24PM
2
Mar 23, 2021 03:27PM
2
Mar 23, 2021 04:33PM
Share
New Message
Please login to post a reply